MITOZYTREX vs TEMODAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MITOZYTREX and TEMODAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MITOZYTREX	TEMODAR
Rating	New	70/100
Pharmacy pays	—	~$148.82 /30
Type	RX	RX
Active ingredient	MITOMYCIN	TEMOZOLOMIDE
Manufacturer	Supergen	Merck Sharp Dohme
Dosage forms	Injectable	Capsule, Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	None	None
Treats	Adenocarcinoma, Urinary Bladder Neoplasms, Pancreatic Neoplasms	Glioblastoma, Melanoma

mitozytrex temodar

Rating

New

70/100

Pharmacy pays

—

~$148.82 /30

Type

Active ingredient

MITOMYCIN

TEMOZOLOMIDE

Manufacturer

Supergen

Merck Sharp Dohme

Dosage forms

Injectable

Capsule, Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Adenocarcinoma, Urinary Bladder Neoplasms, Pancreatic Neoplasms

Glioblastoma, Melanoma

Frequently asked questions

What is the difference between Mitozytrex and Temodar?

Mitozytrex contains Mitomycin, while Temodar contains Temozolomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.